ATE353909T1 - 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon - Google Patents

3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon

Info

Publication number: ATE353909T1
Authority: AT; Austria
Prior art keywords: nitrogen; steroid compounds; dioxygenated steroid; dioxygenated; compounds
Prior art date: 2000-04-28

Application number

AT01925262T

Other languages

English (en)

Inventor

Jeffery R Raymond

Claudia E Kasserra

Yaping Shen

Original Assignee

Inflazyme Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-28

Filing date

2001-04-30

Publication date

2007-03-15

2001-04-30 Application filed by Inflazyme Pharm Ltd filed Critical Inflazyme Pharm Ltd

2007-03-15 Application granted granted Critical

2007-03-15 Publication of ATE353909T1 publication Critical patent/ATE353909T1/de

Links

-1 STEROID COMPOUNDS Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
- C07J41/0011—Unsubstituted amino radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
- C07J71/0047—Nitrogen only at position 2(3)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
- C07J71/0063—Nitrogen and oxygen at position 2(3)
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT01925262T 2000-04-28 2001-04-30 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon ATE353909T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20061700P	2000-04-28	2000-04-28

Publications (1)

Publication Number	Publication Date
ATE353909T1 true ATE353909T1 (de)	2007-03-15

Family

ID=22742458

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01925262T ATE353909T1 (de)	2000-04-28	2001-04-30	3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon

Country Status (33)

Country	Link
US (4)	US6635629B2 (de)
EP (1)	EP1278763B1 (de)
JP (1)	JP2003531916A (de)
KR (1)	KR20030045671A (de)
CN (1)	CN1214039C (de)
AP (1)	AP1825A (de)
AT (1)	ATE353909T1 (de)
AU (2)	AU2001252084B2 (de)
BG (1)	BG107289A (de)
BR (1)	BR0110419A (de)
CA (1)	CA2418748A1 (de)
CO (1)	CO5590904A2 (de)
DE (1)	DE60126597T2 (de)
DK (1)	DK1278763T3 (de)
DZ (1)	DZ3355A1 (de)
EE (1)	EE200200613A (de)
ES (1)	ES2282247T3 (de)
HR (1)	HRP20020944A2 (de)
HU (1)	HUP0300908A2 (de)
IL (2)	IL152448A0 (de)
MA (1)	MA25808A1 (de)
MX (1)	MXPA02010645A (de)
NO (1)	NO324873B1 (de)
NZ (1)	NZ522181A (de)
OA (1)	OA12255A (de)
PL (1)	PL365798A1 (de)
PT (1)	PT1278763E (de)
RU (1)	RU2291873C2 (de)
SK (1)	SK15692002A3 (de)
UA (1)	UA79229C2 (de)
WO (1)	WO2001083512A1 (de)
YU (1)	YU88102A (de)
ZA (1)	ZA200208631B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030083231A1 (en) *	1998-11-24	2003-05-01	Ahlem Clarence N.	Blood cell deficiency treatment method
CA2418748A1 (en) *	2000-04-28	2001-11-08	Inflazyme Pharmaceuticals Limited	3-nitrogen-6,7-dioxygen steroids and uses related thereto
AU2002303425A1 (en) *	2001-04-24	2002-11-05	Epigenesis Pharmaceuticals, Inc.	Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
NZ546612A (en)	2001-05-22	2007-08-31	Inflazyme Pharm Ltd	Process for the production of 6,7-dihydroxy steroid compounds by allylic oxidation of steroid-5-ene compounds to steroid-5-ene-7-one compounds followed by hydroboration and oxidation intermediates of this process
WO2004013173A1 (ja)	2002-08-01	2004-02-12	Yamanouchi Pharmaceutical Co., Ltd.	新規なカリウム依存的ナトリウム−カルシウム交換体
US20050026879A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) *	2003-07-31	2009-12-03	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) *	2003-07-31	2005-05-26	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) *	2003-07-31	2005-02-24	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) *	2003-07-31	2009-11-19	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20110209699A1 (en) *	2003-07-31	2011-09-01	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) *	2003-07-31	2009-10-22	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) *	2003-07-31	2005-05-12	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) *	2003-07-31	2009-12-24	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) *	2003-07-31	2005-02-17	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
FR2861077B1 (fr) *	2003-10-20	2006-03-03	Aventis Pharma Sa	Formes cristallines du chlorydrate de 3-beta-amino, 17-methylene, androstane-6-alpha, 7-beta-diol
EP1680441A1 (de) *	2003-10-20	2006-07-19	Inflazyme Pharmaceuticals, Ltd.	Kristalline formen von 3-beta-amino-17-methylenandrostan-6-alpha-7-beta-diol-hydrochlorid
US20080051382A1 (en) *	2003-10-20	2008-02-28	Inflazyme Pharmaceuticals Ltd.	Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride
US20090317477A1 (en) *	2004-03-31	2009-12-24	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
US20050222049A1 (en) *	2004-03-31	2005-10-06	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
US20050227927A1 (en) *	2004-03-31	2005-10-13	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis
JP2011504184A (ja) *	2007-11-21	2011-02-03	ザプロクターアンドギャンブルカンパニー	咳治療に有用な製剤、方法及びキット
JP5655243B2 (ja) *	2009-10-19	2015-01-21	国立大学法人熊本大学	インドキシル硫酸の産生の阻害剤のスクリーニング方法、インドキシル硫酸代謝産生阻害剤、及び腎障害軽減剤
AU2011206864B2 (en)	2010-01-15	2013-12-19	Suzhou Neupharma Co., Ltd.	Certain chemical entities, compositions, and methods
KR20230156435A (ko)	2010-07-09	2023-11-14	바이오버라티브 테라퓨틱스 인크.	인자 iｘ 폴리펩티드 및 이들의 사용 방법
EP2670763B1 (de)	2011-02-02	2018-08-01	Suzhou Neupharma Co., Ltd	Bestimmte chemische stoffe, zusammensetzungen und verfahren
CN109354598A (zh)	2012-04-29	2019-02-19	润新生物公司	化学个体、药物组合物及癌症治疗方法
EP3542861A1 (de)	2012-09-25	2019-09-25	Bioverativ Therapeutics Inc.	Verfahren zur verwendung von fix-polypeptiden
JP6407951B2 (ja)	2013-03-14	2018-10-17	アクイノックスファーマシューティカルズ（カナダ）インコーポレイテッド	Ｓｈｉｐ１モジュレーターおよびそれに関連する組成物および方法
BR112015022577A2 (pt)	2013-03-14	2017-07-18	Aquinox Pharmaceuticals Canada Inc	moduladores ship1 e métodos relacionados a esse
AR095527A1 (es)	2013-03-15	2015-10-21	Biogen Idec Inc	Formulaciones de polipéptido fc-factor ix
CN104744547B (zh) *	2013-12-27	2017-02-15	天津医科大学	一种抗乳腺癌转移作用的孕甾烷生物碱衍生物及医药用途
AU2016281658A1 (en)	2015-06-26	2017-12-07	Aquinox Pharmaceuticals (Canada) Inc.	Crystalline solid forms of the acetate salt of (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methyleneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexanol
AU2017209430A1 (en)	2016-01-20	2018-07-12	Aquinox Pharmaceuticals (Canada) Inc.	Synthesis of a substituted indene derivative
US11420962B2 (en)	2018-04-06	2022-08-23	Taro Pharmaceuticals Inc.	Indene derivatives useful in treating pain and inflammation
JP2021526546A (ja)	2018-04-06	2021-10-07	アキノックスファーマシューティカルス（カナダ）インク．	疼痛及び炎症を治療するのに有用なインデン誘導体
WO2019195692A1 (en)	2018-04-06	2019-10-10	Aquinox Pharmaceuticals (Canada) Inc.	Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3682983A (en) *	1969-11-12	1972-08-08	Klaus Prezewowsky	Preparation of {66 {11 {11 -17 ethinyl steroids
US4548922A (en) *	1983-06-06	1985-10-22	Beth Israel Hospital	Drug administration
ATE188036T1 (de)	1990-01-18	2000-01-15	Cura Nominees Pty Ltd	Glykoalkaloide
US5877185A (en)	1991-10-22	1999-03-02	Octamer, Inc.	Synergistic compositions useful as anti-tumor agents
CA2086221C (en)	1992-12-23	2003-07-15	Raymond J. Andersen	Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent
DK0688333T3 (da)	1993-03-10	1999-02-08	Magainin Pharma	Steroidderivater, farmaceutiske præparater indeholdende disse og deres anvendelse som antibiotika eller desinfektionsmidler
US5817632A (en) *	1993-08-16	1998-10-06	Hsia; Jen-Chang	Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5856535A (en) *	1994-08-18	1999-01-05	Magainin Pharmaceuticals, Inc.	Aminosterol ester compounds
US6083532A (en) *	1995-03-01	2000-07-04	Duramed Pharmaceuticals, Inc.	Sustained release formulation containing three different types of polymers and tablet formed therefrom
WO1996036230A1 (en)	1995-05-16	1996-11-21	The Salk Institute For Biological Studies	Modulators for new members of the steroid/thyroid superfamily of receptors
US5847172A (en) *	1995-06-07	1998-12-08	Magainin Pharmaceuticals Inc.	Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5874597A (en)	1995-06-07	1999-02-23	Magainin Pharmaceuticals, Inc.	Certain aminosterol compounds and pharmaceutical compositions including these compounds
US6046185A (en)	1996-07-11	2000-04-04	Inflazyme Pharmaceuticals Ltd.	6,7-oxygenated steroids and uses related thereto
US6060465A (en)	1997-02-06	2000-05-09	Miljkovic; Dusan	Bile acids and their derivatives as glycoregulatory agents
AU759333B2 (en)	1998-03-06	2003-04-10	Brigham Young University	Steroid derived antibiotics
CA2418748A1 (en) *	2000-04-28	2001-11-08	Inflazyme Pharmaceuticals Limited	3-nitrogen-6,7-dioxygen steroids and uses related thereto

2001
- 2001-04-30 CA CA002418748A patent/CA2418748A1/en not_active Abandoned
- 2001-04-30 PT PT01925262T patent/PT1278763E/pt unknown
- 2001-04-30 JP JP2001580936A patent/JP2003531916A/ja active Pending
- 2001-04-30 AU AU2001252084A patent/AU2001252084B2/en not_active Ceased
- 2001-04-30 AU AU5208401A patent/AU5208401A/xx active Pending
- 2001-04-30 ES ES01925262T patent/ES2282247T3/es not_active Expired - Lifetime
- 2001-04-30 CN CNB018101674A patent/CN1214039C/zh not_active Expired - Fee Related
- 2001-04-30 HU HU0300908A patent/HUP0300908A2/hu unknown
- 2001-04-30 NZ NZ522181A patent/NZ522181A/en unknown
- 2001-04-30 HR HR20020944A patent/HRP20020944A2/xx not_active Application Discontinuation
- 2001-04-30 YU YU88102A patent/YU88102A/sh unknown
- 2001-04-30 DZ DZ013355A patent/DZ3355A1/fr active
- 2001-04-30 EE EEP200200613A patent/EE200200613A/xx unknown
- 2001-04-30 DE DE60126597T patent/DE60126597T2/de not_active Expired - Lifetime
- 2001-04-30 DK DK01925262T patent/DK1278763T3/da active
- 2001-04-30 WO PCT/CA2001/000581 patent/WO2001083512A1/en not_active Ceased
- 2001-04-30 MX MXPA02010645A patent/MXPA02010645A/es active IP Right Grant
- 2001-04-30 AP APAP/P/2002/002659A patent/AP1825A/en active
- 2001-04-30 RU RU2002131941/04A patent/RU2291873C2/ru not_active IP Right Cessation
- 2001-04-30 EP EP01925262A patent/EP1278763B1/de not_active Expired - Lifetime
- 2001-04-30 AT AT01925262T patent/ATE353909T1/de not_active IP Right Cessation
- 2001-04-30 BR BR0110419-5A patent/BR0110419A/pt not_active IP Right Cessation
- 2001-04-30 IL IL15244801A patent/IL152448A0/xx active IP Right Grant
- 2001-04-30 UA UA2002119460A patent/UA79229C2/uk unknown
- 2001-04-30 PL PL01365798A patent/PL365798A1/xx not_active Application Discontinuation
- 2001-04-30 OA OA1200200328A patent/OA12255A/en unknown
- 2001-04-30 US US09/845,775 patent/US6635629B2/en not_active Expired - Fee Related
- 2001-04-30 KR KR1020027014524A patent/KR20030045671A/ko not_active Ceased
- 2001-04-30 US US10/258,950 patent/US20040034216A1/en not_active Abandoned
- 2001-04-30 SK SK1569-2002A patent/SK15692002A3/sk unknown
2002
- 2002-10-24 NO NO20025106A patent/NO324873B1/no unknown
- 2002-10-24 ZA ZA200208631A patent/ZA200208631B/en unknown
- 2002-10-24 IL IL152448A patent/IL152448A/en not_active IP Right Cessation
- 2002-11-19 BG BG107289A patent/BG107289A/bg unknown
- 2002-11-20 MA MA26916A patent/MA25808A1/fr unknown
- 2002-11-22 CO CO02106292A patent/CO5590904A2/es not_active Application Discontinuation
2003
- 2003-07-21 US US10/624,946 patent/US7112580B2/en not_active Expired - Fee Related
2006
- 2006-07-28 US US11/496,052 patent/US20070060553A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60126597T2 (de)	2007-10-31
CO5590904A2 (es)	2005-12-30
AP1825A (en)	2008-02-03
WO2001083512A1 (en)	2001-11-08
MXPA02010645A (es)	2004-04-20
AP2002002659A0 (en)	2002-12-31
CA2418748A1 (en)	2001-11-08
HUP0300908A2 (hu)	2003-07-28
NO20025106D0 (no)	2002-10-24
CN1430625A (zh)	2003-07-16
YU88102A (sh)	2006-01-16
PT1278763E (pt)	2007-05-31
US20040034216A1 (en)	2004-02-19
IL152448A0 (en)	2003-05-29
UA79229C2 (en)	2007-06-11
DK1278763T3 (da)	2007-06-11
US7112580B2 (en)	2006-09-26
HRP20020944A2 (en)	2004-02-29
ES2282247T3 (es)	2007-10-16
DE60126597D1 (de)	2007-03-29
JP2003531916A (ja)	2003-10-28
US20020072510A1 (en)	2002-06-13
OA12255A (en)	2006-05-11
NO20025106L (no)	2002-12-18
US6635629B2 (en)	2003-10-21
EP1278763B1 (de)	2007-02-14
PL365798A1 (en)	2005-01-10
US20040138186A1 (en)	2004-07-15
CN1214039C (zh)	2005-08-10
ZA200208631B (en)	2004-02-23
US20050215534A9 (en)	2005-09-29
EE200200613A (et)	2004-04-15
KR20030045671A (ko)	2003-06-11
MA25808A1 (fr)	2003-07-01
EP1278763A1 (de)	2003-01-29
AU2001252084B2 (en)	2006-07-06
SK15692002A3 (sk)	2003-11-04
RU2291873C2 (ru)	2007-01-20
IL152448A (en)	2006-12-31
NZ522181A (en)	2005-04-29
AU5208401A (en)	2001-11-12
NO324873B1 (no)	2007-12-17
HK1050694A1 (en)	2003-07-04
US20070060553A1 (en)	2007-03-15
DZ3355A1 (fr)	2001-11-08
BG107289A (bg)	2003-07-31
BR0110419A (pt)	2004-02-25

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1278763

Country of ref document: EP

2010-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60126597D1 (de)	2007-03-29	3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon
DE60003874D1 (de)	2003-08-21	Resistmaterialien und Verbindungen
DE60111734D1 (de)	2005-08-04	[1,4']-bipiperidin verbindungen
DE50112013D1 (de)	2007-03-22	Deodorantien und antiperspirantien
EP1296699A4 (de)	2005-02-16	Therapeutische verbindungen
ATE397928T1 (de)	2008-07-15	Glukokinase beeinflussende verbindungen
EP1311531A4 (de)	2009-10-28	Von steroiden abgeleitete antibiotika
DE60236099D1 (de)	2010-06-02	Druckverfahren, druckerzeugnisse und drucksteuerung
EP1197204A4 (de)	2006-01-25	Deodorantien
MXPA03001425A (es)	2003-06-06	Compuestos farmaceuticos.
ATE327978T1 (de)	2006-06-15	Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
DE60139422D1 (de)	2009-09-10	Polyarylenether-polyolefinzusammensetzung und formassen daraus
DE60144265D1 (de)	2011-05-05	Halbleiterbauelement und dessen herstelllung
DE60136003D1 (de)	2008-11-13	Tryptamin-derivative und analoge verbindungen, und
DE60227657D1 (de)	2008-08-28	1-OXA-3,9-DIAZASPIROc5.5ÜUNDECAN-2-ONDERIVATE UND ZEPTORS
DE60114039D1 (de)	2006-02-23	Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
DE60228478D1 (de)	2008-10-02	Aryl-annellierte azapolyzyklische verbindungen
DE50104376D1 (de)	2004-12-09	Düngerstreuer
DE60005282D1 (de)	2003-10-23	Golfschlägerkopf, golfschläger und golfschlägerset
MXPA03001857A (es)	2003-06-04	Composicones medicinales.
EE200300564A (et)	2004-02-16	Püridüülmetüülaminopürimidiiniühendid, nende kasutamine ja ravim
ATA16102001A (de)	2005-06-15	Klemmvorrichtung
ES1050686Y (es)	2002-08-16	Bolsa perfeccionada.
FI20000669L (fi)	2001-09-23	Sisäsäkki
NL1015622A1 (nl)	2002-01-08	Ventilatie-inrichting.